Versions 1.26.1 and 1.26.2 of Microsoft's agent-framework PyPI package, published November 17, contain Python startup hooks that harvest cloud and CI/CD credentials and attempt to obtain identity ...
点击上方“Deephub Imba”,关注公众号,好文章不错过 !数据分块可以把超大文档拆成 AI ...
Anthropic opened an investigation into elevated errors affecting five Claude models on October 25, 2026, posting an incident on the Claude Status page at 06:14 UTC that lists claude.ai, the Claude API ...
Startup Recursive has released Flint, a free, laptop-sized coding model built largely by its own AI research system, as an early test of AI that improves itself.
For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Sometimes, the game plays to the scouting report. The AL-best Tampa Bay Rays are known for putting pressure on the defense and the New York Yankees are not known for pristine glovework. Both of those ...
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.